Updated European guidelines for coeliac disease in children

Sukriti Ray1, Peter Michael Gillett2, Vicki Le Huray3

  • 1Brighton and Sussex Medical School, Brighton, England.

Insights

The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) updated guidelines in 2020 for diagnosing paediatric coeliac disease. These revised guidelines simplify diagnosis and management for children with this condition.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Nutrition

Background:

  • Coeliac disease is an autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals.
  • Accurate and timely diagnosis is crucial for managing paediatric coeliac disease and preventing long-term complications.
  • Previous diagnostic approaches required invasive procedures, posing challenges in paediatric populations.

Purpose of the Study:

  • To provide an update for clinicians on the diagnosis and management of paediatric coeliac disease.
  • To highlight the key changes and implications of the revised European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines.
  • To offer a practical overview of streamlined diagnostic pathways for coeliac disease in children.

Main Methods:

  • Review of the updated 2020 European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines.
  • Synthesis of current literature on paediatric coeliac disease diagnosis and management.
  • Analysis of streamlined diagnostic approaches and their clinical applicability.

Main Results:

  • The revised ESPGHAN guidelines introduce a more streamlined diagnostic pathway for paediatric coeliac disease.
  • These updates aim to simplify the detection of coeliac disease in children, potentially reducing the need for invasive testing.
  • The guidelines provide a framework for clinicians to effectively diagnose and manage the condition.

Conclusions:

  • The updated ESPGHAN guidelines offer a simplified and efficient approach to diagnosing paediatric coeliac disease.
  • Clinicians should familiarize themselves with these revised guidelines for optimal patient care.
  • Implementing these changes can lead to earlier diagnosis and improved management of coeliac disease in children.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
387
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
137
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
224
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
142
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
188
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
174